openPR Logo
Press release

Central Nervous System Therapeutic Market Trends, Size, Share and Forecast 2023-2029

02-02-2023 11:41 AM CET | Health & Medicine

Press release from: Orion Market Research

Central Nervous System Therapeutic Market Trends, Size, Share

The global central nervous therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period. The growing number of central nervous disorders across the globe is significantly contributing to the growth of the global central nervous system therapeutic market. The prevalence of Alzheimer's disease, multiple sclerosis, epilepsy, Parkinson's disease, mental health and stroke are significantly growing across the globe. For instance, as per the World Health Organization (WHO), epilepsy is a chronic non-communicable disease of the brain which affects the brain around 50 million people across the globe are suffering from this disease and is one of the most common neurological diseases. Depression is a common mental disorder, around 5% of adults across the globe suffered from depression. It is a leading cause of disability across the globe. This, in turn, is driving the demand for treatment for these disorders, which in turn, is accelerating the market growth.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/central-nervous-system-therapeutic-market

Some new launches of CNS drugs have been witnessed across the globe. For instance, in April 2021, Optimus Pharma announced that it has received approval for its Anti-Parkinson drug Safinamide in India. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episodes. Optimus believes Safinamide will give an additional option to healthcare professionals in the treatment of Parkinson's and improve the quality of life of millions who are affected by Parkinson's disease. A homegrown generic version of Safinamide developed by Optimus will assist in delivering robust treatment for Parkinson's diseases in India with very high affordability and accessibility.

Market Coverage

• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Indication
o By Application
o By Drug Class
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Biogen Inc., and Eli Lilly, and Company Inc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Çentral Nervous Therapeutic Market Report by Segment

By Indication

• Neurovascular Diseases
• CNS Trauma
• Mental Health
• Neurodegenerative Diseases
• Infectious Diseases
• Cancer

By Application

• Hospital & Clinic
• Homecare
• Others

By Drug Class

• Immunomodulatory Drugs
• Interferons
• Decarboxylase Inhibitors
• Dopamine Agonists
• Antidepressants
• Others

A full report of Central Nervous System Therapeutic Market is available at: https://www.omrglobal.com/industry-reports/central-nervous-system-therapeutic-market

Central Nervous System Therapeutic Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AstraZeneca plc
• Cipla Ltd.
• CNS Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• H. Lundbeck A/S
• Lupin Ltd.
• Medopharm Private Ltd.
• Neurelis, Inc.
• Nuventra Pharma Sciences
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Sanofi S.A.
• Shire plc

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit More Report at

https://www.asiatimeskorea.com/press-release/%ea%b4%91%ea%b2%ac%eb%b3%91-%eb%a9%b4%ec%97%ad%ea%b8%80%eb%a1%9c%eb%b6%88%eb%a6%b0-%ec%8b%9c%ec%9e%a5-%ec%84%b1%ec%9e%a5-%ec%a0%90%ec%9c%a0%ec%9c%a8-%eb%8f%99%ed%96%a5-%eb%b0%8f-%ea%b0%9c%ec%9a%94-2/170451/

https://www.diario-ya.com/regionales/2022-2028-%e5%b9%b4%e7%b4%a7%e6%80%a5%e5%8c%bb%e7%96%97%e6%9c%8d%e5%8a%a1%e5%b8%82%e5%9c%ba%e8%a7%84%e6%a8%a1%e3%80%81%e4%bb%bd%e9%a2%9d%e3%80%81%e8%a1%8c%e4%b8%9a%e5%a2%9e%e9%95%bf%e3%80%81%e5%88%86/251616/

https://sportmsr.com/%d8%ad%d8%ac%d9%85-%d8%b3%d9%88%d9%82-%d9%86%d8%b8%d9%85-%d9%85%d8%b1%d8%a7%d9%82%d8%a8%d8%a9-%d9%86%d8%b3%d8%a8%d8%a9-%d8%a7%d9%84%d8%ac%d9%84%d9%88%d9%83%d9%88%d8%b2-%d9%81%d9%8a-%d8%a7%d9%84%d8%af/

https://revistaeconomiasocial.com/2022/12/12/copa-menstrual-tamano-del-mercado-participacion-crecimiento-de-la-industria-analisis-y-pronostico-2022-2028/

https://hy-icehockey.jp/%e3%83%86%e3%82%af%e3%83%8e%e3%83%ad%e3%82%b8%e3%83%bc/%e5%a4%96%e6%9d%a5ehr%e5%b8%82%e5%a0%b4%e3%81%ae%e6%88%90%e9%95%b7%e3%80%81%e3%82%b7%e3%82%a7%e3%82%a2%e3%80%81%e5%82%be%e5%90%91%e3%80%81%e3%81%8a%e3%82%88%e3%81%b3%e6%a6%82%e8%a6%812022%e5%b9%b4/51838/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Central Nervous System Therapeutic Market Trends, Size, Share and Forecast 2023-2029 here

News-ID: 2910233 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Parkinson

Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025? The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period? The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $1.43 billion
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%. Increasing Geriatric Population Driving Demand: The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,